Individualized care for symptoms, sexual health, and healthy aging
Menopause is reached after 12 consecutive months without a menstrual period when no other medical cause explains the change. Postmenopause describes the years that follow.
Lower estrogen and other hormonal changes may affect comfort, sleep, sexual health, bone health, body composition, and quality of life.
At Copper Rock Clinic, we base your treatment on your symptoms, health history, lab results, goals, and preferences.
Symptoms may include:
Some symptoms improve over time. Vaginal and urinary symptoms may continue or worsen without treatment.
Copper Rock Clinic offers several delivery methods:
Some women prefer the flexibility of patches or creams. Others prefer the convenience of longer-lasting pellets. We explain the advantages and limitations of each option.
Estrogen is the most effective treatment for hot flashes and night sweats. It may also relieve vaginal symptoms and help prevent bone loss while you continue therapy.
The appropriate treatment depends on:
Women with a uterus generally need progesterone when using systemic estrogen. Progesterone protects the uterine lining from overstimulation.
Oral micronized progesterone may also support sleep in some women. Women who have had a hysterectomy may not require it.
Testosterone may be considered for appropriately evaluated women experiencing distressing loss of sexual desire after other contributing factors have been addressed.
Research by Dr. Rebecca Glaser and others has explored testosterone implant therapy in women, including symptom response, tolerability, and long-term outcomes. Broader consensus recognizes the strongest evidence for carefully dosed testosterone in postmenopausal women with hypoactive sexual desire disorder.
Treatment is individualized and monitored to avoid excessive exposure and unwanted androgenic effects.
Pellets are placed beneath the skin during a brief office procedure and gradually release hormone over several months.
Potential advantages include:
Pellet therapy is widely used by thousands of physicians, nurse practitioners, and physician assistants nationwide.
Copper Rock Clinic follows the EvexiPEL® method, emphasizing:
After insertion, pellets cannot be easily removed. We discuss their expected duration, possible side effects, and alternative delivery methods before treatment.
Hormone therapy is not one medication with one universal risk profile. The hormone, dose, delivery method, timing, progesterone selection, and individual patient all matter.
In February 2026, the FDA approved the removal of boxed-warning statements concerning breast cancer, cardiovascular disease, and probable dementia from several menopausal hormone-therapy products.
This does not mean every risk has disappeared. It reflects a more current understanding that older warnings did not accurately represent every patient, treatment, or delivery method.
The endometrial-cancer warning remains for systemic estrogen used alone in women with a uterus. Providers generally prescribe appropriate progesterone to protect the uterine lining.
https://www.fda.gov/news-events/press-announcements/fda-approves-labeling-changes-menopausal-hormone-therapy-productsRead the FDA announcement
Oral estrogen passes through the liver first. This can affect clotting proteins and is associated with a greater risk of venous blood clots than transdermal estradiol.
Transdermal estradiol—including patches, gels, and creams—avoids first-pass liver metabolism. Research consistently associates transdermal estradiol with a lower blood-clot risk than oral estrogen.
Estradiol pellets also bypass first-pass liver metabolism. Although direct clot-risk studies involving pellets are more limited than those involving patches, pellets should not automatically be assigned the same risk profile as oral estrogen.
https://pubmed.ncbi.nlm.nih.gov/26544651/Review the oral-versus-transdermal estrogen study
https://link.springer.com/article/10.1007/s00404-022-06647-5Read the systematic review
Depending on the patient and treatment selected, hormone therapy may help:
For many healthy women who begin treatment before age 60 or within approximately 10 years of menopause, current evidence supports a favorable benefit-risk profile when therapy is appropriately selected and monitored.
Hormone therapy is not appropriate for everyone. Before treatment, we evaluate factors such as:
Possible side effects depend on the hormones and delivery method selected.
Pellet insertion may cause temporary soreness, bruising, swelling, bleeding, infection, or—less commonly—pellet extrusion.
We review your symptoms, medical history, medications, screenings, previous treatments, and goals.
We select tests based on your history and proposed treatment. Results are interpreted alongside your symptoms.
We discuss pellets, patches, creams, injections, oral progesterone, vaginal therapy, and nonhormonal options.
Follow-up may include symptom assessment, side-effect review, laboratory testing, and treatment adjustments.
Estradiol, progesterone, and testosterone are established medications found in FDA-approved hormone therapies. Approval applies to a specific product, formulation, delivery method, dose, and indication.
Off-label prescribing is common throughout medicine and may be appropriate when supported by clinical judgment and an individual patient’s needs.
Most customized estradiol and testosterone pellets are compounded and not individually FDA-approved. They can still be prescribed when clinically appropriate with informed consent, individualized dosing, and appropriate monitoring.
Your plan may also address:
Natural menopause is generally diagnosed after 12 consecutive months without a menstrual period when there is no other medical explanation.
There is no universal stopping age. Continuing treatment depends on your symptoms, risks, goals, and ongoing evaluation.
No. It may also address night sweats, vaginal symptoms, painful intercourse, bone loss, and certain sexual-health concerns.
If you have a uterus and use systemic estrogen, progesterone is generally needed to protect the uterine lining.
No method is best for everyone. Pellets offer convenience and consistent delivery, while patches and creams are easier to adjust or discontinue.
Oral estrogen is associated with a greater blood-clot risk than transdermal estradiol because it passes through the liver first. Patches and pellets avoid this first-pass metabolism, although direct clot-risk studies involving pellets remain more limited.
Duration varies by hormone, dose, metabolism, and individual response. Women commonly return for reassessment approximately every three to four months.
Pellet therapy has been used clinically for decades and is offered by thousands of licensed providers. Most customized estradiol and testosterone pellets are compounded and not individually FDA-approved. Off-label and compounded prescribing are used throughout medicine when clinically appropriate.
Schedule a menopause consultation with Copper Rock Clinic to explore pellets, patches, creams, injections, oral progesterone, and other personalized options.
Book an Appointment or call 435-900-1210.